Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutyl isonitrile.
The clinical application of Tc-99m Sestamibi imaging in acute myocardial infarction should be most useful. The capability of assessing risk area during acute coronary occlusion and degree of myocardial salvage after reperfusion offers a noninvasive means to assess the benefit of therapeutic interventions aimed at reducing myocardial ischemic injury. Further studies in larger numbers of patients appear warranted to identify the precise worth of this new imaging technique relative to other existing noninvasive imaging methodologies in clinical practice.
Beller
G A
GA
Department of Medicine, University of Virginia Health Sciences Center, Charlottesville 22908.
Sinusas
A J
AJ
Watson
D D
DD
D000818:Animals; D003287:Contrast Media; D003327:Coronary Disease / Q000000981:diagnostic imaging; D004195:Disease Models, Animal; D004285:Dogs; D006321:Heart / Q000000981:diagnostic imaging*; D006801:Humans; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000188:drug therapy; D015428:Myocardial Reperfusion Injury / Q000000981:diagnostic imaging; D009570:Nitriles; D015609:Organotechnetium Compounds; D011877:Radionuclide Imaging; D017256:Technetium Tc 99m Sestamibi; D015912:Thrombolytic Therapy
D003287:Contrast Media; D009570:Nitriles; D015609:Organotechnetium Compounds; D017256:Technetium Tc 99m Sestamibi